{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:09:13Z","timestamp":1792800553517,"version":"4.5.0"},"reference-count":55,"publisher":"Impact Journals, LLC","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2019,2,15]]},"DOI":"10.18632\/oncotarget.26680","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T14:06:11Z","timestamp":1550239571000},"page":"1458-1472","source":"Crossref","is-referenced-by-count":27,"title":["Adenovirus based virus-like-vaccines targeting endogenous retroviruses can eliminate growing colorectal cancers in mice"],"prefix":"10.18632","volume":"10","author":[{"given":"Lasse","family":"Neukirch","sequence":"first","affiliation":[{"name":"University of Copenhagen, Center for Medical Parasitology, The Panum Institute, DK2200 Copenhagen, Denmark"},{"name":"Clinical Cooperation Unit Applied Tumor Immunity, National Center for Tumor Diseases and German Cancer Research Center, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tea Kirkegaard","family":"Nielsen","sequence":"additional","affiliation":[{"name":"University of Copenhagen, Center for Medical Parasitology, The Panum Institute, DK2200 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"Laursen","sequence":"additional","affiliation":[{"name":"University of Copenhagen, Center for Medical Parasitology, The Panum Institute, DK2200 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Daradoumis","sequence":"additional","affiliation":[{"name":"University of Copenhagen, Center for Medical Parasitology, The Panum Institute, DK2200 Copenhagen, Denmark"},{"name":"InProTher ApS, DK2200 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Thirion","sequence":"additional","affiliation":[{"name":"Sirion Biotech GmbH, 82152 Planegg-Martinsried, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Johannes","family":"Holst","sequence":"additional","affiliation":[{"name":"University of Copenhagen, Center for Medical Parasitology, The Panum Institute, DK2200 Copenhagen, Denmark"},{"name":"InProTher ApS, DK2200 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2019,2,15]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1742-4690-8-90","article-title":"Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses","volume":"8","author":"Coffin","year":"2011","journal-title":"Retrovirology"},{"key":"2","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/ijc.29003","article-title":"Human endogenous retrovirus K and cancer: Innocent bystander or tumorigenic accomplice?","volume":"137","author":"Glynn","year":"2015","journal-title":"Int J Cancer"},{"key":"3","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1093\/nar\/gkp1214","article-title":"Custom human endogenous retroviruses dedicated microarray identifies self-induced HERV-W family elements reactivated in testicular cancer upon methylation control","volume":"38","author":"Mallet","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"4","doi-asserted-by":"publisher","first-page":"84093","DOI":"10.18632\/oncotarget.11455","article-title":"Activation of HERV-K Env protein is essential for tumorigenesis and metastasis of breast cancer cells","volume":"7","author":"Wang-Johanning","year":"2016","journal-title":"Oncotarget"},{"key":"5","doi-asserted-by":"publisher","first-page":"e1002709","DOI":"10.1371\/journal.ppat.1002709","article-title":"Negative selection by an endogenous retrovirus promotes a higher-avidity CD4+ T cell response to retroviral infection","volume":"8","author":"Kassiotis","year":"2012","journal-title":"PLoS Pathog"},{"key":"6","doi-asserted-by":"publisher","first-page":"40095","DOI":"10.18632\/oncotarget.5539","article-title":"Expression of young HERV-H loci in the course of colorectal carcinoma and correlation with molecular subtypes","volume":"6","author":"Mallet","year":"2015","journal-title":"Oncotarget"},{"key":"7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/apm.12478","article-title":"Expression and regulation of human endogenous retrovirus W elements","volume":"124","author":"Karlsson","year":"2016","journal-title":"APMIS"},{"key":"8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1006451","article-title":"A human endogenous retrovirus-derived gene that can contribute to oncogenesis by activating the ERK pathway and inducing migration and invasion","volume":"13","author":"Dewannieux","year":"2017","journal-title":"PLoS Pathog"},{"key":"9","doi-asserted-by":"publisher","first-page":"e70399","DOI":"10.1371\/journal.pone.0070399","article-title":"The Transmembrane Protein of the Human Endogenous Retrovirus - K (HERV-K) Modulates Cytokine Release and Gene Expression","volume":"8","author":"Denner","year":"2013","journal-title":"PLoS One"},{"key":"10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/jnci\/djr540","article-title":"Immunotherapeutic potential of anti-human endogenous retrovirus-k envelope protein antibodies in targeting breast tumors","volume":"104","author":"Hunt","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/00002371-200003000-00001","article-title":"The envelope protein of an endogenous murine retrovirus is a tumor-associated T-cell antigen for multiple murine tumors","volume":"23","author":"Perry-Lalley","year":"2000","journal-title":"J Immunother"},{"key":"12","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1158\/1078-0432.CCR-14-3197","article-title":"Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on Melanoma","volume":"21","author":"Maiti","year":"2015","journal-title":"Clin Cancer Res"},{"key":"13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0072756","article-title":"Vaccination Directed against the Human Endogenous Retrovirus-K Envelope Protein Inhibits Tumor Growth in a Murine Model System","volume":"8","author":"Schnierle","year":"2013","journal-title":"PLoS One"},{"key":"14","doi-asserted-by":"crossref","first-page":"9730","DOI":"10.1073\/pnas.93.18.9730","article-title":"The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product","volume":"93","author":"Jaffee","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15","doi-asserted-by":"crossref","first-page":"9178","DOI":"10.1128\/JVI.73.11.9178-9186.1999","article-title":"Sequence and insertion sites of murine melanoma-associated retrovirus","volume":"73","author":"Gorelik","year":"1999","journal-title":"J Virol"},{"key":"16","doi-asserted-by":"publisher","first-page":"e26889","DOI":"10.4161\/onci.26889","article-title":"Murine leukemia virus envelope gp70 is a shared biomarker for the high-sensitivity quantification of murine tumor burden","volume":"2","author":"Huang","year":"2013","journal-title":"Oncoimmunology"},{"key":"17","first-page":"4954","article-title":"Exp ression and Modulation of a Retrovirus-associated Antigen by Murine Melanoma Cells Expression and Modulation of a Retrovirus-associated Melanoma Cells Antigen by Murine","volume":"48","author":"Hearing","year":"1988","journal-title":"Cancer Res"},{"key":"18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.virol.2010.06.004","article-title":"Effects of retroviral envelope-protein cleavage upon trafficking, incorporation, and membrane fusion","volume":"405","author":"Sanders","year":"2010","journal-title":"Virology"},{"key":"19","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1128\/JVI.72.8.6537-6545.1998","article-title":"Moloney murine leukemia virus envelope protein subunits, gp70 and Pr15E, form a stable disulfide-linked complex","volume":"72","author":"Garoff","year":"1998","journal-title":"J Virol"},{"key":"20","doi-asserted-by":"publisher","first-page":"20534","DOI":"10.1073\/pnas.0707873105","article-title":"Placental syncytins: Genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins","volume":"104","author":"Heidmann","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"21","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.1073\/pnas.0913122107","article-title":"Retroviral infection in vivo requires an immune escape virulence factor encrypted in the envelope protein of oncoretroviruses","volume":"107","author":"Heidmann","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s12026-007-0039-6","article-title":"A potent immunosuppressive retroviral peptide: Cytokine patterns and signaling pathways","volume":"41","author":"Day-Good","year":"2008","journal-title":"Immunol Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"14920","DOI":"10.1073\/pnas.95.25.14920","article-title":"Tumor cells expressing a retroviral envelope escape immune rejection in vivo","volume":"95","author":"Heidmann","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"24","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1158\/0008-5472.CAN-04-4231","article-title":"Endogenous Retrovirus Expression Is Required for Murine Melanoma Tumor Growth In vivo","volume":"65","author":"Heidmann","year":"2005","journal-title":"Cancer Res"},{"key":"25","first-page":"468","article-title":"Immunotherapy with monoclonal antibodies directed against the immunosuppressive domain of p15E inhibits tumour growth","volume":"102","author":"Van Ewijk","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"26","first-page":"2771","article-title":"Effect of anti-B16 melanoma monoclonal antibody on established murine B16 melanoma liver metastases","volume":"47","author":"Rosenberg","year":"1987","journal-title":"Cancer Res"},{"key":"27","doi-asserted-by":"publisher","first-page":"5893","DOI":"10.1073\/pnas.84.16.5893","article-title":"Role of antibodies to murine leukemia virus p15E transmembrane protein in immunotherapy against AKR leukemia: a model for studies in human acquired immunodeficiency syndrome","volume":"84","author":"Schafer","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ijc.2910470126","article-title":"Suppression of established pulmonary metastases by murine melanoma-specific monoclonal antibodies","volume":"47","author":"Law","year":"1991","journal-title":"Int J Cancer"},{"key":"29","first-page":"7920","article-title":"Immunization against endogenous retroviral tumor-associated antigens","volume":"61","author":"Hwu","year":"2001","journal-title":"Cancer Res"},{"key":"30","doi-asserted-by":"publisher","first-page":"6396","DOI":"10.4049\/jimmunol.171.12.6396","article-title":"Effective Genetic Vaccination with a Widely Shared Endogenous Retroviral Tumor Antigen Requires CD40 Stimulation during Tumor Rejection Phase","volume":"171","author":"Zanovello","year":"2003","journal-title":"J Immunol"},{"key":"31","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S1074-7613(00)00052-2","article-title":"Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex","volume":"13","author":"Pardoll","year":"2000","journal-title":"Immunity"},{"key":"32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/vaccines6010010","article-title":"Virus-Like-Vaccines against HIV","volume":"6","author":"Holst","year":"2018","journal-title":"Vaccines"},{"key":"33","doi-asserted-by":"publisher","first-page":"5344","DOI":"10.1016\/j.vaccine.2016.08.089","article-title":"Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations","volume":"34","author":"Holst","year":"2016","journal-title":"Vaccine"},{"key":"34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0168-1702(02)00316-7","article-title":"Budding and secretion of HIV Gag-Env virus-like particles from recombinant human adenovirus infected cells","volume":"92","author":"Kang","year":"2003","journal-title":"Virus Res"},{"key":"35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-016-1102-7","article-title":"Increased T cell breadth and antibody response elicited in prime-boost regimen by viral vector encoded homologous SIV Gag\/Env in outbred CD1 mice","volume":"14","author":"Holst","year":"2016","journal-title":"J Transl Med"},{"key":"36","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.vaccine.2017.01.016","article-title":"Novel adenovirus encoded virus-like particles displaying the placental malaria associated VAR2CSA antigen","volume":"35","author":"Holst","year":"2017","journal-title":"Vaccine"},{"key":"37","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1038\/sj.gt.3302361","article-title":"Multiple gene products from a single vector: \u201cself-cleaving\u201d 2A peptides","volume":"11","author":"Mitrophanous","year":"2004","journal-title":"Gene Ther"},{"key":"38","doi-asserted-by":"publisher","first-page":"11651","DOI":"10.1128\/JVI.77.21.11651-11660.2003","article-title":"Murine leukemia virus particle assembly quantitated by fluorescence microscopy: role of Gag-Gag interactions and membrane association","volume":"77","author":"Collins","year":"2003","journal-title":"J Virol"},{"key":"39","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.molimm.2009.03.008","article-title":"Virus-like particle vaccine activates conventional B2 cells and promotes B cell differentiation to IgG2a producing plasma cells","volume":"46","author":"Yao","year":"2009","journal-title":"Mol Immunol"},{"key":"40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-065X.1987.tb00521.x","article-title":"Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes","volume":"98","author":"Braciale","year":"1987","journal-title":"Immunol Rev"},{"key":"41","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1200\/JCO.2004.10.041","article-title":"Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance","volume":"22","author":"Sykes","year":"2004","journal-title":"J Clin Oncol"},{"key":"42","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/0042-6822(79)90557-9","article-title":"Monoclonal antibodies against murine leukemia viruses: Identification of six antigenic determinants on the p15(E) and gp70 envelope proteins","volume":"98","author":"Nowinski","year":"1979","journal-title":"Virology"},{"key":"43","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition","volume":"39","author":"Desai","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"44","doi-asserted-by":"publisher","first-page":"11774","DOI":"10.1073\/pnas.1410626111","article-title":"Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells","volume":"111","author":"Zhou","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"45","doi-asserted-by":"publisher","first-page":"201","DOI":"10.7497\/j.issn.2095-3941.2015.0046","article-title":"Fueling the engine and releasing the break: combinational therapy of cancer vaccines and immune checkpoint inhibitors","volume":"12","author":"Zheng","year":"2015","journal-title":"Cancer Biol Med"},{"key":"46","doi-asserted-by":"publisher","first-page":"419","DOI":"10.4161\/onci.19534","article-title":"Combined vaccination and immunostimulatory antibodies provides durable cure of murine melanoma and induces transcriptional changes associated with positive outcome in human melanoma patients","volume":"1","author":"Bramson","year":"2012","journal-title":"Oncoimmunology"},{"key":"47","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1038\/sj.gt.3302616","article-title":"Purification of adenovirus and adeno-associated virus: comparison of novel membrane-based technology to conventional techniques","volume":"12","author":"Strappe","year":"2005","journal-title":"Gene Ther"},{"key":"48","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1128\/JVI.01597-10","article-title":"Multiple innate immune pathways contribute to the immunogenicity of recombinant adenovirus vaccine vectors","volume":"85","author":"Barouch","year":"2011","journal-title":"J Virol"},{"key":"49","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1006\/cimm.2000.1691","article-title":"Anti-tumor immunity against CT26 colon tumor in mice immunized with plasmid DNA encoding \u03b2-galactosidase fused to an envelope protein of endogenous retrovirus","volume":"204","author":"Wanaka","year":"2000","journal-title":"Cell Immunol"},{"key":"50","doi-asserted-by":"publisher","first-page":"E966","DOI":"10.1073\/pnas.1500712112","article-title":"Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK","volume":"112","author":"Levy","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"51","doi-asserted-by":"publisher","first-page":"7715","DOI":"10.1038\/s41598-017-07851-z","article-title":"Luciferase Expression Allows Bioluminescence Imaging But Imposes Limitations on the Orthotopic Mouse (4T1) Model of Breast Cancer","volume":"7","author":"Chekhonin","year":"2017","journal-title":"Sci Rep"},{"key":"52","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/bit.24342","article-title":"Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors","volume":"109","author":"Hill","year":"2011","journal-title":"Biotechnol Bioeng"},{"key":"53","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0091-679X(08)60603-2","article-title":"Use of recombinant adenovirus for metabolic engineering of mammalian cells","volume":"43","author":"Newgard","year":"1994","journal-title":"Methods Cell Biol"},{"key":"54","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.4049\/jimmunol.178.3.1662","article-title":"Agonistic anti-CD40 antibody profoundly suppresses the immune response to infection with lymphocytic choriomeningitis virus","volume":"178","author":"Thomsen","year":"2007","journal-title":"J Immunol"},{"key":"55","first-page":"3698","article-title":"The Effect of Estrone-Progesterone Treatment on Cell Proliferation Kinetics of Hormone-dependent GR Mouse Mammary Tumors The Effect of Estrone-Progesterone Treatment on Cell Proliferation Kinetics of Hormone-dependent GR Mouse Mammary Tumors","volume":"3","author":"Hartmann","year":"1975","journal-title":"Cancer Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.26680","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T10:32:46Z","timestamp":1588847566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.26680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,15]]},"references-count":55,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2019,2,15]]}},"alternative-id":["26680","30858929"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.26680","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,15]]}}}